NAT2 and acute myeloid leukemia: Among the five SNPs (NAT2 (rs1799930 and rs1799931), IDH1 (rs121913500), and IDH2 (rs121913502 and rs1057519736)) that we analyzed to study the relationship between single nucleotide polymorphisms (SNPs) and the risk and overall survival of AML in Jordanian patients we found that NAT2 rs1799930 is the only SNP to show a statistically significant difference in genotype frequency between cases and controls (p = 0.023), while other SNPs did not correlate with the risk and survival of AML in our population.